Drug profile · INN
sulfur
BENSULFOID
sulfur (BENSULFOID) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Drug details — sulfur
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 8
- Programs
- 0
- Data quality
- 0.84
Quick answer
sulfur (BENSULFOID) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related patents
-
US 11015023
Fire retardant compositions utilizing elemental sulfur
granted -
US 10833330
Sulfur composites and polymeric materials from elemental sulfur
granted -
US 10421722
Sulfur-containing compounds targeting vesicular acetylcholine transporter
granted -
US 10125139
Pesticidally active polycyclic derivatives with sulfur substituted five-membered ring heterocycles
granted -
US 9796728
Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof
granted -
US 9567439
Sulfur composites and polymeric materials from elemental sulfur
granted -
US 7595326
Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs
granted -
US 7541463
Sulfur-containing naphthalimide derivatives
granted
Frequently asked questions
What is sulfur?
sulfur (BENSULFOID) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for sulfur?
BENSULFOID is a marketed brand name for sulfur. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfur?
sulfur has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.